Announcements Trials
Browse Landscape

Phase

Phase NA 86Phase 2 40Phase 1 25Phase 3 20Phase 1/2 16Phase 2/3 5Phase EARLY_PHASE1 2Phase 4 2

Status

Unknown 12Completed 7Recruiting 5Active not recruiting 3Withdrawn 2Terminated 1

Sponsor Class

OTHER 3OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Neoplasms 23Carcinoma, Non-Small-Cell Lung 15Prostatic Neoplasms 14Stomach Neoplasms 12Colorectal Neoplasms 12Breast Neoplasms 12Pancreatic Neoplasms 11Leukemia, Myeloid, Acute 10Neoplasm Metastasis 9Lung Neoplasms 9Hematologic Neoplasms 9Head and Neck Neoplasms 9Endometrial Neoplasms 9Carcinoma, Hepatocellular 9Squamous Cell Carcinoma of Head and Neck 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Ovarian Neoplasms 8Myasthenia Gravis 7Melanoma 7Uterine Cervical Neoplasms 6Recurrence 6Rectal Neoplasms 6Neoplasms by Site 6Neoplasms by Histologic Type 6Lymphoma 6Leukemia 6Urinary Bladder Neoplasms 5Neoplasms, Plasma Cell 5Infections 5Colonic Neoplasms 5

Interventions

pembrolizumab 1cyclopropapyrroloindole 1Positron Emission Tomography Computed Tomography 1Oxaliplatin 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Recruiting × Colonic Neoplasms × Clear all
NCT07462143 2026-05-22

A Phase â…¡/â…¢ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer

RemeGen Co., Ltd.

Phase 2/3 Recruiting
80 enrolled
Gastrointestinal

Colonic Neoplasms

NCT05174169 2026-05-06

CIRCULATE-US

NRG Oncology

Phase 2/3 Recruiting
1,912 enrolled
Gastrointestinal

Colonic Neoplasms

NCT05179889 2026-03-19

Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

Chungnam National University Hospital

Phase 2/3 Recruiting
308 enrolled
Gastrointestinal

Colonic Neoplasms

NCT07272772 2025-12-09

Colon Cancer Diagnosis With FAPI-PET Imaging

Turku University Hospital

Phase 2/3 Recruiting
100 enrolled
Gastrointestinal

Colonic Neoplasms

NCT03755739 2024-06-25

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Second Affiliated Hospital of Guangzhou Medical University

Phase 2/3 Recruiting
200 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡